Bailleus has a price target of 80-85 cents. Definitely undervalued. If they get it right, $2-3 stock in coming years.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025